Showing 1 - 20 results of 40 for search 'Lars A. Akslen', query time: 0.06s Refine Results
  1. 1
    β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma

    β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma by Cornelia Schuster, Lars A. Akslen, Oddbjørn Straume

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.

    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Stu... by Cornelia Schuster, Lars A Akslen, Oddbjørn Straume

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry

    Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry by Hanna Røgenes, Kenneth Finne, Ingeborg Winge, Lars A. Akslen, Lars A. Akslen, Arne Östman, Arne Östman, Vladan Milosevic

    Published 2024-04-01
    Get full text
    Article
  4. 4
    Deblender: a semi−/unsupervised multi-operational computational method for complete deconvolution of expression data from heterogeneous samples

    Deblender: a semi−/unsupervised multi-operational computational method for complete deconvolution of expression data from heterogeneous samples by Konstantina Dimitrakopoulou, Elisabeth Wik, Lars A. Akslen, Inge Jonassen

    Published 2018-11-01
    Get full text
    Article
  5. 5
    Prognostic value of immune biomarkers in melanoma loco-regional metastases.

    Prognostic value of immune biomarkers in melanoma loco-regional metastases. by Emilia Hugdahl, Sura Aziz, Tor A Klingen, Lars A Akslen

    Published 2025-01-01
    Get full text
    Article
  6. 6
    An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer.

    An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer. by Monica Mannelqvist, Elisabeth Wik, Ingunn M Stefansson, Lars A Akslen

    Published 2014-01-01
    Get full text
    Article
  7. 7
    Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer

    Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer by Ying Chen, Tor Audun Klingen, Hans Aas, Elisabeth Wik, Lars A Akslen

    Published 2021-09-01
    Get full text
    Article
  8. 8
    Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer.

    Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer. by Tor A Klingen, Ying Chen, Hans Aas, Elisabeth Wik, Lars A Akslen

    Published 2021-01-01
    Get full text
    Article
  9. 9
    CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis

    CD47 and CD68 expression in breast cancer is associated with tumor‐infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis by Ying Chen, Tor Audun Klingen, Hans Aas, Elisabeth Wik, Lars A Akslen

    Published 2023-05-01
    Get full text
    Article
  10. 10
    Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer.

    Strong Expression of Hypoxia-Inducible Factor-1α (HIF-1α) Is Associated with Axl Expression and Features of Aggressive Tumors in African Breast Cancer. by Hawa Nalwoga, Lavina Ahmed, Jarle B Arnes, Henry Wabinga, Lars A Akslen

    Published 2016-01-01
    Get full text
    Article
  11. 11
    VEGFA gene variants are associated with breast cancer progression

    VEGFA gene variants are associated with breast cancer progression by Jessica Furriol, Elisabeth Wik, Sura Aziz, Cecilie Askeland, Gøril Knutsvik, Lars A Akslen

    Published 2024-09-01
    Get full text
    Article
  12. 12
    Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.

    Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. by Emilia Hugdahl, Ingeborg M Bachmann, Cornelia Schuster, Rita G Ladstein, Lars A Akslen

    Published 2019-01-01
    Get full text
    Article
  13. 13
    FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer

    FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer by Astrid Børretzen, Karsten Gravdal, Svein A Haukaas, Christian Beisland, Lars A Akslen, Ole J Halvorsen

    Published 2019-10-01
    Get full text
    Article
  14. 14
    Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarrays.

    Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microar... by Gøril Knutsvik, Ingunn M Stefansson, Sura Aziz, Jarle Arnes, Johan Eide, Karin Collett, Lars A Akslen

    Published 2014-01-01
    Get full text
    Article
  15. 15
    The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients

    The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients by Astrid Børretzen, Karsten Gravdal, Svein A Haukaas, Monica Mannelqvist, Christian Beisland, Lars A Akslen, Ole J Halvorsen

    Published 2021-05-01
    Get full text
    Article
  16. 16
    Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseResearch in context

    Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseResearch in context by Hilde E. Lien, Hege F. Berg, Mari K. Halle, Jone Trovik, Ingfrid S. Haldorsen, Lars A. Akslen, Camilla Krakstad

    Published 2023-06-01
    Get full text
    Article
  17. 17
    Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595]

    Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 10459... by Hilde E. Lien, Hege F. Berg, Mari K. Halle, Jone Trovik, Ingfrid S. Haldorsen, Lars A. Akslen, Camilla Krakstad

    Published 2023-12-01
    Get full text
    Article
  18. 18
    Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55.

    Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. by Ali Ozhand, Eunjung Lee, Anna H Wu, Merete Ellingjord-Dale, Lars A Akslen, Roberta McKean-Cowdin, Giske Ursin

    Published 2013-01-01
    Get full text
    Article
  19. 19
    Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer.

    Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. by Sura Aziz, Elisabeth Wik, Gøril Knutsvik, Tor Audun Klingen, Ying Chen, Benedicte Davidsen, Hans Aas, Turid Aas, Lars A Akslen

    Published 2017-01-01
    Get full text
    Article
  20. 20
    Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer.

    Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer. by Sura Aziz, Elisabeth Wik, Gøril Knutsvik, Tor Audun Klingen, Ying Chen, Benedicte Davidsen, Hans Aas, Turid Aas, Lars A Akslen

    Published 2016-01-01
    Get full text
    Article

Search Tools: